课题基金 / 基金详情

Ultracentrifugation system for purification of synthetic biology constructs

Ultracentrifugation system for purification of synthetic biology constructs
用于纯化合成生物学构建体的超速离心系统
批准号:
RTI-2021-00109
负责人:
deBoer, Carl
金额:
$7.35万
依托单位国家:
加拿大
项目类别:
Research Tools and Instruments
财政年份:
2020
资助国家:
加拿大
项目状态:
已结题
起止时间:
2020-01-01 至 2021-12-31

项目摘要

项目成果

deBoer, Carl的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Ultracentrifuges are vital pieces of laboratory infrastructure that enable purification and isolation of cellular components based on minute differences in their density. Many of the labs in the School of Biomedical Engineering (SBME) routinely use ultracentrifugation to concentrate and purify nucleic acids, proteins, subcellular components, and viruses. In particular, our labs use ultracentrifugation in purifying gene delivery vehicles, such as plasmids and lentivirus, for mammalian transgenesis of synthetic genetic devices. The recent increase in the number of research labs with genetic engineering and synthetic biology expertise in the SBME has resulted in our need for ultracentrifugation outstripping the capabilities of our existing ultracentrifuge setup. Further, the existing unit is nearing the end of its life and we will be left with no alternative when it fails. Accordingly, we have an urgent need for a new ultracentrifuge to avoid significant and unnecessary delays to our work and degradation of the quality of our research. The requested ultracentrifuge will meet the growing needs of our research groups and the SBME, while providing an opportunity for our HQP to learn how to operate a vital piece of equipment. Since all within SBME will have access to it, this ultracentrifuge will support the research and training of many HQP: approximately 43 HQP have plans to use this ultracentrifuge, including 17 HQP in the labs of the applicants. In addition to numerous other applications, ultracentrifugation is a key step in modern mammalian transgenics, providing our HQP with the opportunity to develop skills in demand for future careers in industry and research. With the growing biotechnology sector in Canada, and gene and cell therapies in particular, the ability to concentrate and purify cellular components is a critical skill for HQP.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular and computational tools for regulatory genomics
  • 批准号:
    RGPIN-2020-05425
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.19万
  • 财政年份:
    2022
  • 负责人:
    deBoer, Carl
  • 依托单位:
Molecular and computational tools for regulatory genomics
  • 批准号:
    RGPIN-2020-05425
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.19万
  • 财政年份:
    2021
  • 负责人:
    deBoer, Carl
  • 依托单位:
Molecular and computational tools for regulatory genomics
  • 批准号:
    RGPIN-2020-05425
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.19万
  • 财政年份:
    2020
  • 负责人:
    deBoer, Carl
  • 依托单位:
Molecular and computational tools for regulatory genomics
  • 批准号:
    DGECR-2020-00036
  • 项目类别:
    Discovery Launch Supplement
  • 资助金额:
    $0.91万
  • 财政年份:
    2020
  • 负责人:
    deBoer, Carl
  • 依托单位:
国内基金
海外基金
基于铁死亡探讨黄芪甲苷调控System/Xc-/GSH/GPX4信号通路在神经损伤性勃起功能障碍治疗中的作用及机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    马轲
  • 依托单位:
Data-driven Recommendation System Construction of an Online Medical Platform Based on the Fusion of Information
TBX1/LKB1轴阻断system Xc活性调控AML细胞铁死亡的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    15.0万元
  • 批准年份:
    2024
  • 负责人:
  • 依托单位:
TET2通过调控BAP1-System Xc-轴促进紫拉非尼诱导的肝细胞癌铁死亡的机制研究
  • 批准号:
    --
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    --
  • 依托单位: